ArticleNeuro-oncology2024

Safety and pharmacokinetics of ONC201 (dordaviprone) administered two consecutive days per week in pediatric patients with H3 K27M-mutant glioma.

Yazmin Odia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.